MARKET

RVPHW

Reviva Pharmaceutcls Hldgs Inc
RVPHW
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
-0.0033
-
0.0636
-
Reviva Pharmaceuticals Granted Nasdaq Extension to Meet Minimum Bid Price Requirement
Reuters · 01/26 07:37
Reviva Pharmaceuticals Reports Phase 3 Success for Brilaroxazine in Treating Schizophrenia Negative Symptoms
Reuters · 01/08 13:02
REVIVA ANNOUNCES PUBLICATION ON CLINICAL VOCAL BIOMARKER DATA FROM THE RECOVER PHASE 3 CLINICAL TRIAL OF BRILAROXAZINE TO TREAT NEGATIVE SYMPTOMS IN SCHIZOPHRENIA
Reuters · 01/08 13:00
Reviva Pharmaceuticals CEO to Present at Sachs Neuroscience Innovation Forum
Reuters · 12/29/2025 13:00
REVIVA PHARMACEUTICALS: RECOVER-2 TRIAL PROJECTED TO COST ABOUT $60 MLN
Reuters · 12/23/2025 13:06
REVIVA PHARMACEUTICALS: NEGATIVE SYMPTOMS/BIPOLAR TRIAL IS PROJECTED TO COST ABOUT $30 MLN
Reuters · 12/23/2025 13:06
Reviva Pharmaceuticals Plans RECOVER-2 Phase 3 Trial for Schizophrenia Drug Brilaroxazine
Reuters · 12/23/2025 13:01
REVIVA ANNOUNCES REGULATORY UPDATE REGARDING THE DEVELOPMENT OF BRILAROXAZINE FOR THE TREATMENT OF SCHIZOPHRENIA
Reuters · 12/23/2025 13:00
More

Webull offers Reviva Pharmaceutcls Hldgs Inc stock information, including NASDAQ: RVPHW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RVPHW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RVPHW stock methods without spending real money on the virtual paper trading platform.